share_log

Ensysce Biosciences | SC 13G: Statement of acquisition of beneficial ownership by individuals-Lincoln Park Capital Fund, LLC(9.99%),Lincoln Park Capital, LLC(9.99%), etc.

Ensysce Biosciences | SC 13G:超过5%持股股东披露文件-Lincoln Park Capital Fund, LLC(9.99%),Lincoln Park Capital, LLC(9.99%)等

2023/02/06 18:34
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息